Niels Fristrup

Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer.

Per-Uno Malmström, Chin-Chen Pan, Michael Borre, 2013, The American journal of pathology.

Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancer

Arndt Hartmann, Rainer Fietkau, Michael Borre, 2012, BJU international.

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Jørgen Kjems, Philippe Lamy, Michael Borre, 2009, Cancer research.